MedPath

JAMP-DOCUSATE SODIUM

JAMP-DOCUSATE SODIUM

Dormant
DIN Number

02283220

Drug Class

Human

Market Date

Sep 28, 2006

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02283220
AIG Number0104351005
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AA02 DOCUSATE SODIUM
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOCUSATE SODIUMActive
Strength: 250 MG / 5 ML
Monograph: DOCUSATE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.